三个患者队列中免疫球蛋白轻链淀粉样变性的全基因组关联研究:与骨髓瘤的比较
该研究对来自德国、英国和意大利的1229例免疫球蛋白轻链(AL)淀粉样变性患者和7526名健康局部对照进行了全基因组关联研究(GWAS),并与3790例多发性骨髓瘤(MM)病例的近期GWAS数据进行比较。结果显示10个位点的单核苷酸多态性(SNP)与AL淀粉样变性易感性相关(P<10-5),其中细胞周期蛋白D1剪接位点rs9344关联最强(P=7.80×10-11),且该SNP在MM中仅边缘显著。数据提示AL淀粉样变性和MM存在共同的遗传易感性,细胞周期蛋白D1在AL淀粉样变性中可能比在MM中作用更突出,但与轻链聚集的联系尚需证实。
要点
- AL淀粉样变性GWAS发现10个位点SNP与疾病关联(P<10-5),包括IRF4结合位点SNP。
- 细胞周期蛋白D1剪接位点rs9344关联最强(P=7.80×10-11),在MM中仅边缘显著。
- SMARCD3附近rs79419269也显著(P=5.2×10-8),提示AL与MM共享遗传易感性。
核心结论
- 数据为AL淀粉样变性和MM存在共同遗传易感性提供了证据。
- 细胞周期蛋白D1在AL淀粉样变性中比在MM中作用更突出,但与轻链聚集的联系尚需证实。
研究设计与样本
- 全基因组关联研究(GWAS),纳入德国、英国和意大利的1229例AL淀粉样变性患者及7526名健康局部对照。
- 与MM比较时使用近期GWAS数据中的3790例MM病例。
主要发现
- AL淀粉样变性中10个位点SNP显示关联证据(P<10-5),且3个样本集结果同质。
- 部分SNP先前已被记录影响MM风险,包括IRF4结合位点的SNP。
- AL淀粉样变性中细胞周期蛋白D1剪接位点rs9344达到最高显著性(P=7.80×10-11),该SNP在MM中仅边缘显著。
- SMARCD3附近rs79419269也显著(P=5.2×10-8),SMARCD3参与染色质重塑。
局限性
- 与轻链聚集的联系尚需证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunoglobulin light chain (AL) amyloidosis is characterized by tissue deposition of amyloid fibers derived from immunoglobulin light chain. AL amyloidosis and multiple myeloma (MM) originate from monoclonal gammopathy of undetermined significance. We wanted to characterize germline susceptibility to AL amyloidosis using a genome-wide association study (GWAS) on 1229 AL amyloidosis patients from Germany, UK and Italy, and 7526 healthy local controls. For comparison with MM, recent GWAS data on 3790 cases were used. For AL amyloidosis, single nucleotide polymorphisms (SNPs) at 10 loci showed evidence of an association at P<10-5 with homogeneity of results from the 3 sample sets; some of these were previously documented to influence MM risk, including the SNP at the IRF4 binding site. In AL amyloidosis, rs9344 at the splice site of cyclin D1, promoting translocation (11;14), reached the highest significance, P=7.80 × 10-11; the SNP was only marginally significant in MM. SNP rs79419269 close to gene SMARCD3 involved in chromatin remodeling was also significant (P=5.2 × 10-8). These data provide evidence for common genetic susceptibility to AL amyloidosis and MM. Cyclin D1 is a more prominent driver in AL amyloidosis than in MM, but the links to aggregation of light chains need to be demonstrated.
引用
- da Silva Filho MI, Försti A, Weinhold N, et al. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma. Leukemia. 2016. PMID: 28025584. doi:10.1038/leu.2016.387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。